Stemtech Corp (STEK) stock
STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $296.22KP/E –Yield –
Stemtech net income
Net income is the profit left for shareholders after every expense, interest and tax.
Stemtech's net income for the twelve months ending Sep 30, 2026 was -$3.51M. For fiscal 2025 it was -$4.05M. The highest annual figure on record is -$8.61K in fiscal 2010.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.05M | – |
| FY2024 | Dec 31, 2024 | -$3.77M | – |
| FY2023 | Dec 31, 2023 | -$5.43M | – |
| FY2022 | Dec 31, 2022 | -$8.54M | – |
| FY2021 | Dec 31, 2021 | -$7.08M | – |
| FY2019 | Aug 31, 2019 | -$33.83K | – |
| FY2018 | Aug 31, 2018 | -$37.27K | – |
| FY2017 | Aug 31, 2017 | -$46.34K | – |
| FY2016 | Aug 31, 2016 | -$28.40K | – |
| FY2015 | Aug 31, 2015 | -$19.84K | – |
| FY2014 | Aug 31, 2014 | -$38.53K | – |
| FY2013 | Aug 31, 2013 | -$31.01K | – |
| FY2012 | Aug 31, 2012 | -$28.97K | – |
| FY2011 | Aug 31, 2011 | -$21.51K | – |
| FY2010 | Aug 31, 2010 | -$8.61K | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | -$478.58K | – |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$292.36K | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$1.25M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$1.48M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$809.41K | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$293.15K | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$1.46M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$396.58K | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$1.17M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$784.16K | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$1.42M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$1.86M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$1.04M | -106.0% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$286.92K | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$2.24M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$518.86K | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $17.42M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$24.95M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$494.74K | – |
| Q3 FY2021CQ3 2020 | May 31, 2021 | -$58.54K | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$166.76K | – |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | -$12.31K | – |
| Q3 FY2019CQ2 2019 | May 31, 2019 | -$6.99K | – |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | -$8.13K | – |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | -$6.40K | – |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | -$10.74K | – |
| Q3 FY2018CQ2 2018 | May 31, 2018 | -$7.32K | – |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | -$8.65K | – |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | -$10.57K | – |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | -$16.89K | – |
| Q3 FY2017CQ2 2017 | May 31, 2017 | -$11.39K | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | -$10.77K | – |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | -$7.42K | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | -$11.13K | – |
| Q3 FY2016CQ2 2016 | May 31, 2016 | -$7.79K | – |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | -$3.68K | – |
| Q1 FY2016CQ4 2015 | Nov 30, 2015 | -$5.80K | – |
| Q4 FY2015CQ3 2015 | Aug 31, 2015 | -$8.06K | – |
See a number that looks wrong?